Diagnóstico y tratamiento del hábito tabáquico en pacientes con enfermedad pulmonar obstructiva crónica. Estudio ADEPOCLE

Abajo Larriba, Ana Beatriz de; Díaz Rodríguez, Ángel; González-Gallego, Javier; Méndez Rodríguez, Enrique; Álvarez Álvarez, María Jesús; Capón Álvarez, Jessica; Peleteiro Cobo, Beatriz; Mahmoud Atoui, Omar; Abajo Olea, Serafín de; Martínez de Mandojana Hernández, Juan.
Nutr. hosp ; 33(4): 954-961, jul.-ago. 2016. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-154925

Documentos relacionados

  1. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
  2. Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD.
  3. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy.
  4. Smoking cessation for people with chronic obstructive pulmonary disease.
  5. Relapse prevention interventions for smoking cessation.
  6. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
  7. Interventions for smokeless tobacco use cessation.
  8. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
  9. [Combinations of pharmacological treatments in smoking cessation. A systematic review].
  10. Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study.